May 25, 2017 - By Marguerite Chambers
Spi Energy Company Limited Ads (NASDAQ:SPI) had a decrease of 35.79% in short interest. SPI’s SI was 48,800 shares in May as released by FINRA. Its down 35.79% from 76,000 shares previously. With 82,700 avg volume, 1 days are for Spi Energy Company Limited Ads (NASDAQ:SPI)’s short sellers to cover SPI’s short positions. The SI to Spi Energy Company Limited Ads’s float is 0.09%. About 2.53M shares traded or 3645.43% up from the average. Spi Energy Co Ltd (ADR) (NASDAQ:SPI) has 0.00% since May 25, 2016 and is . It has underperformed by 16.70% the S&P500.
Beacon Trust Company decreased Bristol Myers Squibb Co (BMY) stake by 58.52% reported in 2016Q4 SEC filing. Beacon Trust Company sold 72,255 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Beacon Trust Company holds 51,211 shares with $2.99 million value, down from 123,466 last quarter. Bristol Myers Squibb Co now has $88.43B valuation. The stock rose 0.46% or $0.24 reaching $54.06. About 2.23 million shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since May 25, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.
Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.16, from 1.13 in 2016Q3. It is negative, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Fiduciary owns 98,230 shares. 151,050 were accumulated by Daiwa Sb Invests. Boulegeris Invs accumulated 36,720 shares. Sand Hill Global Limited Company stated it has 0.06% in Bristol-Myers Squibb Co (NYSE:BMY). Andra Ap reported 104,000 shares. Cim Inv Mangement Inc, Pennsylvania-based fund reported 6,596 shares. Edge Asset Mngmt Inc, Washington-based fund reported 172,497 shares. Alpha Cubed Invests Ltd Liability holds 2.32% or 165,299 shares. Parkside Retail Bank And has invested 0.51% in Bristol-Myers Squibb Co (NYSE:BMY). Oz Mgmt Lp reported 1.32 million shares. Ims Cap stated it has 1.27% in Bristol-Myers Squibb Co (NYSE:BMY). Peapack Gladstone Finance has 0% invested in Bristol-Myers Squibb Co (NYSE:BMY). 8,765 were reported by Fic. 13,579 are held by Lakeview Cap Ltd Liability Company. 51,143 were reported by Mackenzie Fincl.
Since February 27, 2017, it had 1 insider purchase, and 6 insider sales for $9.91 million activity. 34,000 shares were sold by ANDREOTTI LAMBERTO, worth $1.91M on Monday, March 27. On Friday, March 3 LEUNG SANDRA sold $5.27M worth of Bristol-Myers Squibb Co (NYSE:BMY) or 92,405 shares. Schmukler Louis S sold $851,220 worth of stock. Caldarella Joseph C sold 8,096 shares worth $463,779. Samuels Theodore R. II had bought 12,000 shares worth $681,240.
Among 17 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. Bristol-Myers Squibb Company had 37 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, January 22 by Berenberg. The rating was maintained by BMO Capital Markets with “Market Perform” on Wednesday, April 5. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Friday, August 5 report. Jefferies maintained the stock with “Hold” rating in Thursday, August 27 report. The stock has “Market Perform” rating by BMO Capital Markets on Monday, January 25. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Hold” rating by Jefferies on Thursday, July 14. On Friday, April 29 the stock rating was maintained by Barclays Capital with “Equal Weight”. Jefferies maintained the stock with “Hold” rating in Tuesday, June 14 report. The firm earned “Hold” rating on Friday, October 28 by Deutsche Bank. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Buy” rating given on Tuesday, September 29 by UBS.
Beacon Trust Company increased Johnson & Johnson (NYSE:JNJ) stake by 2,768 shares to 39,061 valued at $4.50 million in 2016Q4. It also upped Unitedhealth Group Inc (NYSE:UNH) stake by 10,333 shares and now owns 41,022 shares. Thor Inds Inc (NYSE:THO) was raised too.
Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on July, 27. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. BMY’s profit will be $1.19 billion for 18.51 P/E if the $0.73 EPS becomes a reality. After $0.84 actual EPS reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -13.10% negative EPS growth.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.